Stifel Financial’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.98M | Buy |
376,448
+22,998
| +7% | +$609K | 0.01% | 882 |
|
|
2025
Q1 | $8.54M | Buy |
353,450
+174,631
| +98% | +$4.22M | 0.01% | 908 |
|
|
2024
Q4 | $7.2M | Buy |
178,819
+47,471
| +36% | +$1.91M | 0.01% | 1013 |
|
|
2024
Q3 | $8.32M | Buy |
131,348
+62,956
| +92% | +$3.99M | 0.01% | 924 |
|
|
2024
Q2 | $3.63M | Buy |
68,392
+44,511
| +186% | +$2.36M | ﹤0.01% | 1326 |
|
|
2024
Q1 | $1.96M | Buy |
23,881
+13,644
| +133% | +$1.12M | ﹤0.01% | 1736 |
|
|
2023
Q4 | $191K | Buy |
+10,237
| New | +$191K | ﹤0.01% | 3070 |
|
|
2021
Q4 | – | Sell |
-20,766
| Closed | -$130K | – | 3475 |
|
|
2021
Q3 | $130K | Sell |
20,766
-100
| -0.5% | -$626 | ﹤0.01% | 3210 |
|
|
2021
Q2 | $125K | Sell |
20,866
-9,442
| -31% | -$56.6K | ﹤0.01% | 3214 |
|
|
2021
Q1 | $192K | Buy |
30,308
+10,676
| +54% | +$67.6K | ﹤0.01% | 3028 |
|
|
2020
Q4 | $111K | Sell |
19,632
-782
| -4% | -$4.42K | ﹤0.01% | 2927 |
|
|
2020
Q3 | $119K | Buy |
20,414
+689
| +3% | +$4.02K | ﹤0.01% | 2732 |
|
|
2020
Q2 | $142K | Sell |
19,725
-1,142
| -5% | -$8.22K | ﹤0.01% | 2661 |
|
|
2020
Q1 | $99K | Sell |
20,867
-13,987
| -40% | -$66.4K | ﹤0.01% | 2592 |
|
|
2019
Q4 | $290K | Buy |
34,854
+12,991
| +59% | +$108K | ﹤0.01% | 2547 |
|
|
2019
Q3 | $162K | Sell |
21,863
-330
| -1% | -$2.45K | ﹤0.01% | 2693 |
|
|
2019
Q2 | $189K | Sell |
22,193
-623
| -3% | -$5.31K | ﹤0.01% | 2731 |
|
|
2019
Q1 | $233K | Buy |
22,816
+502
| +2% | +$5.13K | ﹤0.01% | 2518 |
|
|
2018
Q4 | $176K | Buy |
22,314
+5,237
| +31% | +$41.3K | ﹤0.01% | 2485 |
|
|
2018
Q3 | $298K | Sell |
17,077
-9,978
| -37% | -$174K | ﹤0.01% | 2363 |
|
|
2018
Q2 | $258K | Buy |
+27,055
| New | +$258K | ﹤0.01% | 2394 |
|